Your browser doesn't support javascript.
loading
Combination treatment with fingolimod and a pathogenic antigen prevents relapse of glucose-6-phosphate isomerase peptide-induced arthritis.
Yoshida, Yuya; Mikami, Norihisa; Matsushima, Yuki; Miyawaki, Mai; Endo, Hiroki; Banno, Rie; Tsuji, Takumi; Fujita, Tetsuro; Kohno, Takeyuki.
Affiliation
  • Yoshida Y; Faculty of Pharmaceutical Sciences, Department of Pathological Biochemistry Setsunan University Osaka Japan.
  • Mikami N; Department of Experimental Immunology Immunology Frontier Research Center Osaka University Osaka Japan.
  • Matsushima Y; Faculty of Pharmaceutical Sciences, Department of Pathological Biochemistry Setsunan University Osaka Japan.
  • Miyawaki M; Faculty of Pharmaceutical Sciences, Department of Pathological Biochemistry Setsunan University Osaka Japan.
  • Endo H; Faculty of Pharmaceutical Sciences, Department of Pathological Biochemistry Setsunan University Osaka Japan.
  • Banno R; Faculty of Pharmaceutical Sciences, Department of Pathological Biochemistry Setsunan University Osaka Japan.
  • Tsuji T; Faculty of Pharmaceutical Sciences, Department of Pathological Biochemistry Setsunan University Osaka Japan.
  • Fujita T; Research Institute for Production and Development Kyoto Japan.
  • Kohno T; Faculty of Pharmaceutical Sciences, Department of Pathological BiochemistrySetsunan UniversityOsakaJapan; Research Institute for Production and DevelopmentKyotoJapan.
Immun Inflamm Dis ; 4(3): 263-73, 2016 Sep.
Article de En | MEDLINE | ID: mdl-27621810

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Immun Inflamm Dis Année: 2016 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Immun Inflamm Dis Année: 2016 Type de document: Article Pays de publication: Royaume-Uni